---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023333"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:20:06.584740+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Juvenescence exercises 377,865 warrants at $13.20 for $4.99M; remaining due Nov 2024 & June 2025

## Summary
- Juvenescence exercised 377,865 post-merger warrants at $13.20/share, generating $4,987,818 in proceeds.
- Upon exercise, Juvenescence also received incentive warrants for 377,865 shares at $18.00, expiring March 26, 2028.
- This exercise is one-third of total post-merger warrants; second third due by Nov 30, 2024, final third by June 30, 2025.
- Proceeds will be used for general corporate purposes.

## SEC filing metadata
- accession: 0001493152-24-023333
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224023333/0001493152-24-023333-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224023333/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023333
- JSON: https://secwatch.observer/filing/0001493152-24-023333.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023333.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.